BiotechTube
Home/Maxona Pharmaceuticals/Gary Maier, Ph.D.
GM

Gary Maier, Ph.D.

Pharmacokinetics

Maxona Pharmaceuticals

Therapeutic Areas

Pain ManagementNeurology

Maxona Pharmaceuticals Pipeline

DrugIndicationPhase
MAX-001Acute and Chronic PainPhase 2

Leadership Team at Maxona Pharmaceuticals

SF
Shawn Fatholahi
President & CEO
RB
Richard Brand
Chief Financial Officer
RF
Roy Freeman, M.D.
Senior Medical Advisor, SAB Chairman
RR
Rob Rubens, M.D.
Clinical Development
JH
Jim Hinson
Regulatory Affairs
View full Maxona Pharmaceuticals profile